HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.

Abstract
The effectiveness of a new first-in-class antibiotic, tigecycline (glycylcycline), was evaluated during the early dissemination (1 week), early immune (3 weeks), or late persistent (4 months) phases of Borrelia burgdorferi infection in C3H mice. Mice were treated with high or low doses of tigecycline, saline (negative-effect controls), or a previously published regimen of ceftriaxone (positive-effect controls). Infection status was assessed at 3 months after treatment by culture, quantitative ospA real-time PCR, and subcutaneous transplantation of joint and heart tissue into SCID mice. Tissues from all saline-treated mice were culture and ospA PCR positive, tissues from all antibiotic-treated mice were culture negative, and some of the tissues from most of the mice treated with antibiotics were ospA PCR positive, although the DNA marker load was markedly decreased compared to that in saline-treated mice. Antibiotic treatment during the early stage of infection appeared to be more effective than treatment that began during later stages of infection. The viability of noncultivable spirochetes in antibiotic-treated mice (demonstrable by PCR) was confirmed by transplantation of tissue allografts from treated mice into SCID mice, with dissemination of spirochetal DNA to multiple recipient tissues, and by xenodiagnosis, including acquisition by ticks, transmission by ticks to SCID mice, and survival through molting into nymphs and then into adults. Furthermore, PCR-positive heart base tissue from antibiotic-treated mice revealed RNA transcription of several B. burgdorferi genes. These results extended previous studies with ceftriaxone, indicating that antibiotic treatment is unable to clear persisting spirochetes, which remain viable and infectious, but are nondividing or slowly dividing.
AuthorsStephen W Barthold, Emir Hodzic, Denise M Imai, Sunlian Feng, Xiaohua Yang, Benjamin J Luft
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 54 Issue 2 Pg. 643-51 (Feb 2010) ISSN: 1098-6596 [Electronic] United States
PMID19995919 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Antigens, Surface
  • Bacterial Outer Membrane Proteins
  • Bacterial Vaccines
  • Lipoproteins
  • OspA protein
  • Tigecycline
  • Ceftriaxone
  • Minocycline
Topics
  • Animals
  • Anti-Bacterial Agents (pharmacology, therapeutic use)
  • Antigens, Surface (genetics)
  • Bacterial Outer Membrane Proteins (genetics)
  • Bacterial Vaccines (genetics)
  • Borrelia burgdorferi (drug effects, genetics, physiology)
  • Ceftriaxone (pharmacology, therapeutic use)
  • Female
  • Lipoproteins (genetics)
  • Lyme Disease (drug therapy, genetics, microbiology)
  • Mice
  • Microbial Sensitivity Tests
  • Minocycline (analogs & derivatives, pharmacology, therapeutic use)
  • Polymerase Chain Reaction
  • Ticks (microbiology)
  • Tigecycline

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: